Sanofi Said to Plan Move Out of Paris Headquarters to Cut CostsBy
Company said to discuss leaving rented site on rue La Boetie
Legal setback on cholesterol drug adds to pressure on expenses
Sanofi, France’s biggest drugmaker, is discussing a move out of its headquarters in central Paris as part of Chief Executive Officer Olivier Brandicourt’s push to save money, according to people familiar with the situation.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.